Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

Autor: De Santis, Pierluigi, Sanna, Valeria, Perrone, Martina, Guarini, Chiara, Santoro, Anna Natalizia, Laface, Carmelo, Carrozzo, Daniela, Oliva, Gaia Rachele, Fancellu, Alessandro, Fedele, Palma

Publikováno v: Journal of Clinical Medicine; Dec2023, Vol. 12 Issue 23, p7325, 13p

Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response.

Autor: De Santis P; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Perrone M; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Guarini C; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Santoro AN; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Laface C; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Carrozzo D; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy., Oliva GR; Department of Medicine and Translational Surgery, Università Cattolica del Sacro Cuore, 00168 Roma, Italy., Fedele P; Oncology Unit, Francavilla Fontana Ceglie Messapica Hospital District, 72021 Francavilla Fontana, Italy.

Publikováno v: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2024; Vol. 5 (1), pp. 232-250. Date of Electronic Publication: 2024 Feb 28.